Home Cart Sign in  
Chemical Structure| 1049731-36-3 Chemical Structure| 1049731-36-3

Structure of Naspm 3HCl
CAS No.: 1049731-36-3

Chemical Structure| 1049731-36-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Naspm 3HCl is a potent and selective Ca2+ permeable AMPA receptor (Ca-perm AMPAR) blocker.

Synonyms: 1-Naphthylacetyl spermine trihydrochloride; Naspm trihydrochloride; 1-Naphthylacetyl spermine

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Naspm 3HCl

CAS No. :1049731-36-3
Formula : C22H37Cl3N4O
M.W : 479.91
SMILES Code : [H]Cl.[H]Cl.[H]Cl.NCCCNCCCCNCCCNC(CC1=C2C=CC=CC2=CC=C1)=O
Synonyms :
1-Naphthylacetyl spermine trihydrochloride; Naspm trihydrochloride; 1-Naphthylacetyl spermine
MDL No. :MFCD01321052

Safety of Naspm 3HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Hippocampal neurons 30 µM From 6 DIV to 13 DIV, twice a day (at 9 am and 5 pm) To evaluate the effect of diosgenin on SPARC expression on axons, results showed that diosgenin significantly increased SPARC expression on axons. PMC8760075
HEK293 cells 100 μM Evaluate the effect of SR9009 on a luciferase reporter driven by the Bmal1 promoter PMC10168695
HEK293 cells 100 μM Evaluate the effect of SR9009 on a luciferase reporter driven by the Bmal1 promoter PMC10168695
PV-FSI 100 µM >5 min Blocking cortical activation of PV-FSIs, mimicking and occluding the effect of mecamylamine on SPN spike latency PMC9142149
Cultured brainstem neurons 5 μM NASPM dose-dependently blocked the NTG-enhanced Ca2+ influx PMC5858972
Bergmann glia 100 μM Used to verify the blocking effect of NASP on Ca2+-permeable AMPA receptors, finding that 100 μM NASP effectively blocked AMPA-induced currents in Bergmann glial cells. PMC2277055
Lamina II neurons 50 μM 10 min To evaluate the effect of IEM-1460 on AMPA receptor-mediated Ca2+ signals, it was found that IEM-1460 inhibited AMPA-mediated Ca2+ transients in CFA 21d mice. PMC6559354

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice GluA2 knockout mice 100 μM Intracellular Not explicitly mentioned In neurons from GluA2 KO mice, NASPM completely blocked the outward component of synaptic currents, whereas spermine could not PMC10168695
Mice AKAP150 ΔPIX and ΔPKA mice 20 μM In vitro brain slice administration Single administration NASPM fully prevented LTP expression induced by the pairing protocol PMC8530450
C57BL/6 mice NTG-induced migraine-like pain model 0.5 μl, 3 mM intra-Sp5C injection Single injection, observed for 6 hours NASPM significantly inhibited NTG-induced mechanical hypersensitivity PMC5858972
C57Bl/6 mice CFA-induced inflammatory pain model 0.01–10 nmol intrathecal Single administration, observed over 240 min To evaluate the effect of naspm on NTX-induced mechanical hypersensitivity, it was found that naspm dose-dependently inhibited NTX-induced mechanical hypersensitivity. PMC6559354

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.08mL

0.42mL

0.21mL

10.42mL

2.08mL

1.04mL

20.84mL

4.17mL

2.08mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories